Navigation Links
IDRI Awarded $314,500 Grant From Murdock Trust to Expand TB Drug Discovery Program
Date:6/25/2009

SEATTLE, June 25 /PRNewswire-USNewswire/ -- The Infectious Disease Research Institute today announced it has received a $314,500 grant from the M.J. Murdock Charitable Trust. This new funding will support IDRI's efforts to better understand the mechanisms of tuberculosis (TB) disease and ultimately identify new drugs to treat it.

TB is a contagious disease spread by tiny droplets in the air and can be hard to avoid. A seemingly insignificant cough from an infected person can spread the infection. Nearly 2 million people die of TB every year and one-third of the planet is infected. With the emergence of multi-drug resistant (MDR) and extensively-drug resistant (XDR) TB strains, the disease is becoming deadlier. The World Health Organization predicts that by 2020 almost one billion people would have contracted TB, with 35 million dying from it.

"Most people believe that TB is a disease of the past or only a disease associated with significant poverty in developing countries, but TB is actually a global problem that threatens developed countries as well," said Professor Tanya Parish, the Principal Investigator for the grant at IDRI. "While XDR-TB is spreading dangerously with cases now reported in 55 countries, no truly novel TB drug has been developed for use in over 40 years. We urgently need new and more effective drugs to fight against TB."

IDRI's TB Drug Discovery Program was created in 2007 with the objective of discovering drugs that shorten the standard tuberculosis antibiotic treatment and new ways to treat drug-resistant forms of the disease. As part of this new endeavor, IDRI joined Eli Lilly and Company and the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to form the Lilly TB Drug Discovery Initiative, a unique public-private partnership dedicated to accelerating early-stage TB drug discovery.

"This is the second grant we have received from the Murdock Trust and we are very appreciative of their renewed support to IDRI's mission against neglected diseases," commented Dr Steve Reed, Founder and Head of IDRI's Research and Development Program. "This funding is essential so that we can harness the most promising science to discover new TB drugs as quickly as possible so as to address this global emergency affecting millions of lives."

IDRI is dedicated to developing products not only to treat, but also to detect and prevent TB. IDRI's scientists have been working on TB vaccine development for more than 15 years under several grants and contracts from the NIAID. This multi-pronged approach aims at bringing the highest value to the global community.

About the M.J. Murdock Charitable Trust

The mission of the M.J. Murdock Charitable Trust is to enrich the quality of life in the Pacific Northwest by providing grants and enrichment programs to organizations seeking to strengthen the region's educational, spiritual, and cultural base in creative and sustainable ways. In addition to a special interest in education and scientific research, the Trust partners with a wide variety of organizations that serve the arts, public affairs, health and medicine, human services, leadership development, and persons with disabilities.

For more information on the M.J. Murdock Charitable Trust, go to www.murdock-trust.org

IDRI-Translating science into global health solutions

IDRI is a Seattle-based not-for-profit organization committed to applying innovative science to the research and development of products to prevent, detect and treat infectious diseases of poverty. By integrating capabilities, IDRI strives to create an efficient pathway bringing scientific innovation from the lab to the people who need it most.

In 2007, IDRI received a first grant from the from the M.J. Murdock Charitable Trust for core research equipment.

For more information on IDRI, go to www.idri.org.

For more information on the Lilly TB Drug Discovery Initiative, go to www.tbdrugdiscovery.org


'/>"/>
SOURCE Infectious Disease Research Institute
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. UVa researcher awarded $3.6 million grant to fight drug-resistant bacteria
2. Southwest Ambulance Awarded Exclusive, 3-Year Contract Extension in Peoria, Arizona
3. CAS Medical Systems, Inc. Awarded $2.8 Million Grant by National Institutes of Health
4. PartsSource Awarded US Patent for PartsFinder(TM) Application
5. Wrigleys Orbit(R), Extra(R) and Eclipse(R) Sugar-Free Chewing Gums Awarded American Dental Associations Seal of Acceptance
6. Insulet Awarded National Accreditation for Excellence by Community Health Accreditation Program
7. Paragon Technologies SI Systems Brand Awarded A $1.0 Million System Expansion Contract for an Automated Light-Picking System
8. UMASS Medical School awarded National Childrens Study contract
9. beBetter Awarded WV Quitline Contract
10. Henricksen Awarded 2007 Distinguished Veterinary Staff Award
11. Lacey Veterinarian Awarded 2007 WSVMA Recent Graduate Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th Annual Kids Fun ... NJ. This free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is ... is geared towards children of all ages; it is a non-competitive, non-timed event, which ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader ... been awarded a contract by the Center for Medicare and Medicaid Services (CMS). ... the enterprise use of Agile methodologies in a consistent and high value manner ...
(Date:10/12/2017)... ... October 12, 2017 , ... First ... compliance program management, will showcase a range of technology and learning solutions at ... (NCAL) Convention and Expo to be held October 14–18, 2017 at the Mandalay ...
(Date:10/12/2017)... Wis. (PRWEB) , ... October 12, 2017 , ... ... standard products to meet the demand of today’s consumer and regulatory authorities worldwide. ... of probiotic experts and tested to meet the highest standard. , These ...
(Date:10/12/2017)... ... 2017 , ... Asante, a nationally recognized health system in ... existing home health joint venture through an agreement, effective October 1, 2017, to ... home health company with Asante, delivering clinically integrated care, for the past eight ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... , Oct. 12, 2017 AVACEN Medical , ... company with their  2017 New Product Innovation Award for ... extensive primary and secondary medical device market research by Frost ... its first-to-market OTC, drug-free pain relief product, the AVACEN 100, ... to treating fibromyalgia widespread pain. ...
(Date:10/11/2017)... , Oct. 11, 2017  Caris Life Sciences ... on fulfilling the promise of precision medicine, today announced ... joined Caris, Precision Oncology Alliance™ (POA) as its 17 ... centers, the St. Jude Crosson Cancer Institute will help ... the use of tumor profiling, making cancer treatment more ...
(Date:10/10/2017)... , Oct. 10, 2017   West Pharmaceutical ... innovative solutions for injectable drug administration, today shared the ... ID Adapter for improving the intradermal administration of polio ... Skin Vaccination Summit in May 2017 by Dr. ... Polio Department, World Health Organization (WHO), and recently published ...
Breaking Medicine Technology: